Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schizophrenia: affect and outcome

T E Gift, J S Strauss, R F Kokes

    The American Journal of Psychiatry
    |May 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.

    The Journal of dermatological treatment·2002
    Same author

    Rosacea fulminans.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2002
    Same author

    Training in pediatric dermatology.

    JAMA·2001
    Same author

    A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne.

    Journal of the American Academy of Dermatology·2001
    Same author

    Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.

    Journal of the American Academy of Dermatology·2001
    Same author

    Some thoughts on rosacea.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2001
    Same journal

    2026 Annual Meeting: President-Elect Address.

    The American journal of psychiatry·2026
    Same journal

    2026 Annual Meeting: CEO and Medical Director's Address.

    The American journal of psychiatry·2026
    Same journal

    Reports to the Membership.

    The American journal of psychiatry·2026
    Same journal

    Convergent Metabolic Dysregulations But Divergent Contributing Pathways Across Severe Mental Disorders: The Power of Combining Genetics and Metabolomics.

    The American journal of psychiatry·2026
    Same journal

    2026 Annual Meeting: Presidential Address.

    The American journal of psychiatry·2026
    Same journal

    Represcribing Previously Used Antipsychotics: Response to So.

    The American journal of psychiatry·2026
    See all related articles

    Schizophrenia patients with affective symptoms do not necessarily have a better outcome. This study found psychotic symptoms predict poor prognosis, but affective symptoms do not significantly impact schizophrenia outcomes.

    Area of Science:

    • Psychiatry and Mental Health
    • Clinical Psychology
    • Neuroscience

    Background:

    • Previous research suggested schizophrenic patients with affective symptoms experience more favorable outcomes.
    • This observation raised questions about differential diagnosis, potentially classifying these patients under affective disorder or schizoaffective psychosis.
    • Methodological limitations in prior studies, including sampling and diagnostic issues, necessitated further investigation.

    Purpose of the Study:

    • To rigorously examine the prognostic power of affective symptoms in schizophrenia.
    • To address methodologic shortcomings of previous studies on schizophrenia outcomes.
    • To clarify the relationship between symptom presentation and long-term prognosis in schizophrenia.

    Main Methods:

    Related Experiment Videos

  • Employed robust methodology to overcome limitations of prior research.
  • Conducted systematic data collection and reliable diagnostic procedures.
  • Assessed a restricted range of outcome measures.

    • Main Results:

    • Schizophrenic patients exhibiting psychotic symptoms showed a correlation with poor outcomes.
    • Affective symptoms in schizophrenia patients demonstrated minimal prognostic power.
    • The study's design aimed to provide more reliable insights into schizophrenia prognosis.

    Conclusions:

    • Affective symptoms do not appear to be a reliable predictor of a favorable outcome in schizophrenia.
    • The presence of psychotic symptoms is a more significant indicator of poor prognosis in schizophrenia.
    • Findings challenge previous assumptions and highlight the importance of symptom-specific prognostic factors in schizophrenia.